Kualitas bukti 4.5/5
Skor tinjauan delapan dimensi terhadap rubrik kualitas . Setiap dimensi dinilai 1–5.
- D1 Dasar sumber
- 4/5
- D2 Otoritas sumber
- 5/5
- D3 Aritmetika
- 4/5
- D4 Ketidakpastian
- 4/5
- D5 Cakupan
- 5/5
- D6 Prosa
- 5/5
- D7 Kejujuran persepsi
- 4/5
- D8 Kelengkapan peringatan
- 5/5
● faktor Anda — klik risiko ini ▾ untuk menampilkan
- Faktor Anda
≈ Sama mungkinnya dengan
Dipersepsikan
Intuisi umum adalah bahwa orang yang benar-benar terganggu pada akhirnya mencari bantuan — bahwa depresi atau kecemasan klinis yang cukup parah untuk memengaruhi kehidupan sehari-hari, cepat atau lambat, akan mendorong seseorang ke dokter atau terapis. Ketika diminta memperkirakan berapa banyak orang dengan depresi yang dapat didiagnosis tidak mendapat pengobatan apa pun dalam satu tahun tertentu, sebagian besar tebakan berada di sekitar 10-20 %. Angka sebenarnya — sekitar 39 % orang dewasa AS dengan episode depresi berat pada 2021 tidak menerima pengobatan kesehatan mental sama sekali — berada jauh di luar kisaran itu. Ketika lensa diperlebar ke semua bentuk penyakit mental klinis, kesenjangan pengobatan naik menjadi hampir setengah: data 2022 SAMHSA menunjukkan bahwa 49,4 % dari 59,3 juta orang dewasa AS dengan penyakit mental apa pun tidak menerima layanan pada tahun itu.
Perkiraan kasar: ~10-20 % orang dengan depresi tidak pernah mencari perawatan
Sumber: intuisi redaksi, bukan hasil survei
Aktual
~39 % orang dewasa AS dengan episode depresi berat pada 2021 tidak menerima pengobatan kesehatan mental pada tahun itu
Orang dewasa AS berusia 18+ yang mengalami episode depresi berat pada 2021
Tampilkan perhitungan
Dua kuantitas digabungkan. Prevalensi seumur hidup gangguan depresi berat di antara orang dewasa AS adalah 16,6 % (95 % CI: 15,4-17,9 %) berdasarkan National Comorbidity Survey Replication (Kessler dkk. 2005, Arch Gen Psychiatry). Di antara orang dewasa yang mengalami episode depresi berat dalam satu tahun tertentu, NIMH melaporkan bahwa 39,0 % tidak menerima pengobatan kesehatan mental pada 2021. Analisis NCS-R Wang dkk. 2005 menemukan bahwa median keterlambatan antara onset gangguan mood dan kontak pengobatan pertama adalah 6-8 tahun, dan 5,8-11,9 % tidak pernah melakukan kontak pengobatan dalam hidup mereka. Dengan asumsi sekitar 50 % kasus MDD seumur hidup melibatkan setidaknya satu tahun penuh tanpa pengobatan — angka pertengahan yang konservatif mengingat batas bawah adalah ~8 % (mereka yang tidak pernah mencari perawatan) dan batas atas mendekati ~90 % (hampir semua orang yang akhirnya mencari pengobatan juga menghabiskan bertahun-tahun sebelum kontak pertama) — menghasilkan: 16,6 % × 50 % = 8,3 %, dibulatkan menjadi 8 %. Pita ketidakpastian 4-14 % mencerminkan: (a) rentang asumsi 50 % (yang secara wajar bisa 30-80 %); (b) variasi demografis dalam akses pengobatan (SAMHSA 2022 melaporkan laki-laki dengan AMI diobati sebesar 41,6 % vs perempuan sebesar 56,9 %); dan (c) variasi perkiraan prevalensi MDD seumur hidup di berbagai studi dan kriteria diagnostik.
Catatan: Entri ini membingkai satu hasil komposit (depresi yang tidak diobati) yang menca…
Entri ini membingkai satu hasil komposit (depresi yang tidak diobati) yang mencampuradukkan beberapa keadaan berbeda: sama sekali tidak ada kontak pengobatan, kontak pengobatan yang tertunda, dan putus pengobatan. Angka 39 % adalah potret tahun terakhir; orang yang dihitung sebagai tidak diobati pada 2021 mungkin telah menerima pengobatan pada tahun-tahun sebelumnya atau sesudahnya. Temuan Wang dkk. bahwa 88-94 % pada akhirnya melakukan kontak pengobatan menunjukkan bahwa tidak-pernah-diobati secara permanen jarang terjadi untuk gangguan mood (~6-12 % seumur hidup), sementara jeda panjang tanpa pengobatan sering terjadi. Entri ini tidak membedakan antara psikoterapi dan farmakoterapi; pasien yang menerima antidepresan tetapi tanpa psikoterapi dihitung sebagai "diobati". Bukti untuk psikoterapi secara khusus (CBT, IPT, aktivasi perilaku) kuat untuk MDD dan gangguan kecemasan, tetapi akses ke terapi lebih terbatas daripada obat oleh cakupan asuransi dan pasokan penyedia layanan. Konsekuensi depresi yang tidak diobati — kronifikasi, kekambuhan, gangguan pekerjaan, komorbiditas kesehatan fisik, risiko bunuh diri — nyata tetapi heterogen; tidak semua episode yang tidak diobati mengarah pada hasil yang parah.
Risiko terkait
Risiko lain dengan tema serupa — untuk menjelajahi ketakutan terkait.
ADHD yang tidak terdiagnosis
Berapa fraksi orang dewasa AS yang memenuhi kriteria diagnostik ADHD tetapi belum pernah menerima diagnosis formal?
Gangguan bipolar
Berapa kemungkinan mengembangkan gangguan bipolar pada suatu saat dalam hidup?
Perilaku seksual kompulsif
Berapa peluang mengembangkan gangguan perilaku seksual kompulsif?
Kegagalan kondom
Seberapa besar peluang hamil saat mengandalkan kondom atau kontrasepsi lain?
Keputusan yang dipengaruhi risiko ini
Pilihan yang bergantung pada risiko ini: bagaimana pertimbangannya ditimbang.
Mencari pengobatan vs. menyembunyikan kecanduan
% menyesal dengan pilihan ini
Ketidakaktifan mendominasi
Penyesalan tidak bertindak 4.3× lebih tinggi
Perawatan kecanduan vs. menghindari
% menyesal dengan pilihan ini
Ketidakaktifan mendominasi
Penyesalan tidak bertindak 1.5× lebih tinggi
Pilih penantang
Roughly 39% of US adults who experienced a major depressive episode in 2021 received no mental health treatment that year, according to National Institute of Mental Health data drawn from the 2021 National Survey on Drug Use and Health. That translates to approximately 8.2 million people who met clinical criteria for major depression and received no psychotherapy, no medication, and no psychiatric consultation during that period. The picture broadens when the lens shifts from depression to all mental illness: SAMHSA’s 2022 NSDUH found that 49.4% of the 59.3 million US adults with any mental illness received no mental health services that year — nearly half. The intuitive assumption that serious impairment drives help-seeking runs into a consistent empirical wall: among the most common and impairing mental health conditions, going without formal care in any given year is the modal outcome, not the exception.
The National Comorbidity Survey Replication data, analyzed by Wang et al. in a 2005 Archives of General Psychiatry paper, adds a longitudinal dimension. Among Americans who ever develop a mood disorder and eventually do seek treatment, the median delay between first onset and first treatment contact is 6 to 8 years. Roughly 5.8 to 11.9% never make treatment contact at all over a lifetime of follow-up. The barriers are not primarily attitudinal at the point of acute distress; they are structural. Cost is cited as the single most common reason for not receiving mental health care in NSDUH self-report data. SAMHSA reports a striking sex gap: males with any mental illness receive treatment at 41.6%, compared to 56.9% for females — a nearly 15-percentage-point difference that tracks with lower male help-seeking across most medical conditions but that is particularly consequential for depression given that male suicide rates are roughly four times higher than female rates.
The barriers the NSDUH data capture are primarily structural rather than a simple failure to recognize illness. SAMHSA’s 2022 survey identifies cost as the leading self-reported reason for not receiving mental health care among adults who perceived a need but did not receive services; insurance gaps, provider shortages, and wait times follow. The sex gap in treatment access — males receiving care at 41.6% versus females at 56.9% — tracks the pattern seen across most medical specialties, but is particularly consequential for depression given that male suicide rates are roughly four times higher than female rates in the US, amplifying the cost of undertreated illness in the population with lower treatment engagement. The Wang et al. longitudinal analysis confirms that the 39% annual snapshot is not a stable equilibrium: most of the people in that 39% are in the pre-treatment phase of a condition they will eventually seek help for — but not for another six to eight years. The entry quantifies access failure, not the absence of a condition requiring attention.
Fakta terkait
~52% orang dewasa dengan gangguan penggunaan zat yang mengatasinya tanpa pengobatan mengatakan penggunaan itu sangat merusak hidup mereka. Dari yang mencari pengobatan, ~12% tidak merasakan manfaatnya. Indikator tidak langsung menunjuk ke arah yang sama.
Pada 2021, ~39% orang dewasa AS dengan episode depresi mayor tidak menerima penanganan kesehatan jiwa apa pun tahun itu, dan sekitar 8% peluang seumur hidup mencakup setidaknya satu tahun depresi mayor tak tertangani. Bahaya tak ditangani lebih sering diremehkan daripada dilebih-lebihkan.
Sekitar 33% orang dewasa AS yang tak pernah mencari terapi menunjukkan permintaan laten akan terapi, sebuah proksi penyesalan karena tidak bertindak. Di antara yang menjalaninya, 27% merasa tidak terbantu. Kedua proksi itu berdekatan.
Buku besar klaim
Setiap angka di bawah ini adalah apa yang dilaporkan masing-masing sumber, dengan kutipan kata demi kata yang kami andalkan dan bagaimana kami sampai pada angka kami. Klik tautan mana saja untuk memverifikasi langsung.
2/5 sumber diverifikasi secara independen kata demi kata terhadap sumber terkutip
-
[1] National Institute of Mental Health (NIMH) — Major Depression: Statistics Terverifikasi
Major Depression: StatisticsSee all 2 Likelier entries citing this source →
- Statistik
8.3% of US adults had past-year MDE in 2021 (21.0 million); 61.0% received treatment; 39.0% received no mental health treatment- Kutipan
“"An estimated 21.0 million adults in the United States had at least one major depressive episode. This number represented 8.3% of all U.S. adults. [...] In 2021, an estimated 61.0% U.S. adults aged 18 or older with major depressive episode received treatment in the past year." ”
- Data sumber dari
- 2023-01-01
- Diakses
- 2026-05-04 · salinan arsip
- Verifikasi
- Kutipan diambil ulang secara independen dan dikonfirmasi kata demi kata terhadap sumber terkutip selama audit pendasaran kami.
- Perhitungan
- Treatment rate 61.0% implies 39.0% no-treatment rate. 21.0 million adults had past-year MDE; 39.0% × 21.0 million = approximately 8.2 million adults with MDE received no treatment in 2021. This is the native figure: 39 in 100 adults with MDE. The NIMH page uses 2021 NSDUH data and does not report lifetime MDD prevalence; the 20% lifetime figure used in the normalized assumptions comes from the NCS-R (Kessler et al. 2005, Arch Gen Psychiatry) and is widely replicated.
-
[2] Substance Abuse and Mental Health Services Administration (SAMHSA) — 2022 National Survey on Drug Use and Health: Key Substance Use and Mental Health Indicators in the United States
2022 National Survey on Drug Use and Health: Key Substance Use and Mental Health Indicators in the United States- Statistik
59.3 million US adults (22.8%) had any mental illness in 2022; 50.6% received mental health services; 49.4% received none- Kutipan
“"Among the 59.3 million adults with AMI in 2022, 50.6 percent received mental health services, meaning that 49.4 percent of adults with AMI did not receive mental health services. [...] Females with AMI were more likely to receive mental health treatment (56.9%) than males with AMI (41.6%)." ”
- Data sumber dari
- 2023-11-01
- Diakses
- 2026-05-04 · salinan arsip
- Perhitungan
- Broader mental illness treatment gap: 49.4% of 59.3 million = 29.3 million adults with any mental illness receiving no services. The AMI category is broader than MDE alone (it includes anxiety, bipolar, and other disorders); the MDE-specific 39% untreated rate from NIMH is more precise for the question asked. Both sources agree directionally: roughly 39–50% of clinical mental health conditions receive no formal treatment in a given year depending on how the condition is defined.
-
[3] Archives of General Psychiatry — Failure and Delay in Initial Treatment Contact After First Onset of Mental Disorders in the National Comorbidity Survey Replication
Failure and Delay in Initial Treatment Contact After First Onset of Mental Disorders in the National Comorbidity Survey Replication- Statistik
Lifetime treatment contact probability for mood disorders: 88.1–94.2%; median delay 6–8 years; 5.8–11.9% of mood disorder cases never make treatment contact- Kutipan
“[Paraphrase from abstract — full text paywalled] The study found that failure to make prompt initial treatment contact is pervasive in the United States. Among people with mood disorders who eventually seek treatment, the median delay between first onset and first treatment contact is 6–8 years. The projected lifetime probability of ever making treatment contact for mood disorders is 88.1%–94.2%, meaning 5.8%–11.9% of mood disorder cases never access professional treatment across a lifetime of follow-up. ”
- Data sumber dari
- 2005-06-01
- Diakses
- 2026-05-04 · salinan arsip
- Perhitungan
- The lifetime no-treatment rate of 5.8–11.9% for mood disorders covers those who never seek care at all. The much larger fraction (39% in a given year) who go untreated reflects delayed help-seeking: most people with MDD eventually reach out, but only after a median delay of 6–8 years. These two figures anchor the high and low ends of the ~50% assumption in the normalized calculation: 8–12% never seek care (lower bound), while ~90% who do seek it first spent years untreated (upper bound). The 50% is the conservative midpoint.
-
[4] Archives of General Psychiatry — Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationSee all 2 Likelier entries citing this source →
- Statistik
Lifetime prevalence of major depressive disorder among US adults: 16.6% (95% CI: 15.4–17.9%)- Kutipan
“[Paraphrase from abstract — full text paywalled] The National Comorbidity Survey Replication found a lifetime prevalence of major depressive disorder of 16.6% (95% CI: 15.4–17.9%) among US adults, based on structured diagnostic interview of a nationally representative sample using DSM-IV criteria. This is the primary epidemiological benchmark for lifetime MDD risk in the United States. ”
- Data sumber dari
- 2005-06-01
- Diakses
- 2026-05-04 · salinan arsip
- Perhitungan
- The 16.6% lifetime MDD prevalence is the multiplier used in the normalized calculation: 16.6% × ~50% (fraction of lifetime MDD cases with at least one untreated year) = 8.3%, rounded to 8% for normalized.lifetime_us_adult. This source is the NCS-R companion paper to Wang et al. 2005 (PMID 15939838); both use the same nationally representative sample. The NIMH MDD statistics page reports only past-year prevalence (8.3% in 2021) and does not publish lifetime prevalence directly; the NCS-R figure is the standard citation.
-
[5] American Foundation for Suicide Prevention (AFSP) — Suicide Statistics Terverifikasi
Suicide StatisticsSee all 2 Likelier entries citing this source →
- Statistik
Suicide-related deaths were four times higher among males (38,977) than among females (9,847)- Kutipan
“"Suicide-related deaths were four times higher among males (38,977) compared to females (9,847)." ”
- Data sumber dari
- 2026-04-07
- Diakses
- 2026-07-04 · salinan arsip
- Verifikasi
- Kutipan diambil ulang secara independen dan dikonfirmasi kata demi kata terhadap sumber terkutip selama audit pendasaran kami.
- Perhitungan
- 38,977 / 9,847 ≈ 3.96, a roughly fourfold male-to-female ratio, consistent with CDC NCHS data showing 22.7 deaths per 100,000 among males vs. 5.9 per 100,000 among females in 2023 (ratio ≈ 3.85). Grounds the body-text comparison of male vs. female suicide rates used to contextualize why the male treatment gap (SAMHSA 2022, above) is particularly consequential.